Global Oxycodone Hydrochloride Capsules Market Analysis and Forecast 2025-2031

Summary

According to APO Research, The global Oxycodone Hydrochloride Capsules market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Oxycodone Hydrochloride Capsules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Oxycodone Hydrochloride Capsules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Oxycodone Hydrochloride Capsules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Oxycodone Hydrochloride Capsules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Oxycodone Hydrochloride Capsules include NAPP PHARMACEUTICALS LIMITED, Allergan, Hikma Pharmaceuticals, Purdue Pharma, Sandoz, Zydus Cadila, Viatris, Lock Pharma and Teva Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes


This report presents an overview of global market for Oxycodone Hydrochloride Capsules, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Oxycodone Hydrochloride Capsules, also provides the revenue of main regions and countries. Of the upcoming market potential for Oxycodone Hydrochloride Capsules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oxycodone Hydrochloride Capsules revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Oxycodone Hydrochloride Capsules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Oxycodone Hydrochloride Capsules revenue, projected growth trends, production technology, application and end-user industry.

Oxycodone Hydrochloride Capsules Segment by Company

NAPP PHARMACEUTICALS LIMITED
Allergan
Hikma Pharmaceuticals
Purdue Pharma
Sandoz
Zydus Cadila
Viatris
Lock Pharma
Teva Pharmaceuticals
Oxycodone Hydrochloride Capsules Segment by Type

5mg
10mg
20mg
Oxycodone Hydrochloride Capsules Segment by Application

Clinic
Hospital
Others
Oxycodone Hydrochloride Capsules Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone Hydrochloride Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxycodone Hydrochloride Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone Hydrochloride Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Oxycodone Hydrochloride Capsules in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Oxycodone Hydrochloride Capsules company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oxycodone Hydrochloride Capsules revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Oxycodone Hydrochloride Capsules Market by Type
1.2.1 Global Oxycodone Hydrochloride Capsules Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 5mg
1.2.3 10mg
1.2.4 20mg
1.3 Oxycodone Hydrochloride Capsules Market by Application
1.3.1 Global Oxycodone Hydrochloride Capsules Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Oxycodone Hydrochloride Capsules Market Dynamics
2.1 Oxycodone Hydrochloride Capsules Industry Trends
2.2 Oxycodone Hydrochloride Capsules Industry Drivers
2.3 Oxycodone Hydrochloride Capsules Industry Opportunities and Challenges
2.4 Oxycodone Hydrochloride Capsules Industry Restraints
3 Global Growth Perspective
3.1 Global Oxycodone Hydrochloride Capsules Market Perspective (2020-2031)
3.2 Global Oxycodone Hydrochloride Capsules Growth Trends by Region
3.2.1 Global Oxycodone Hydrochloride Capsules Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Oxycodone Hydrochloride Capsules Market Size by Region (2020-2025)
3.2.3 Global Oxycodone Hydrochloride Capsules Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Oxycodone Hydrochloride Capsules Revenue by Players
4.1.1 Global Oxycodone Hydrochloride Capsules Revenue by Players (2020-2025)
4.1.2 Global Oxycodone Hydrochloride Capsules Revenue Market Share by Players (2020-2025)
4.1.3 Global Oxycodone Hydrochloride Capsules Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Oxycodone Hydrochloride Capsules Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Oxycodone Hydrochloride Capsules Key Players Headquarters & Area Served
4.4 Global Oxycodone Hydrochloride Capsules Players, Product Type & Application
4.5 Global Oxycodone Hydrochloride Capsules Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Oxycodone Hydrochloride Capsules Market CR5 and HHI
4.6.3 2024 Oxycodone Hydrochloride Capsules Tier 1, Tier 2, and Tier 3
5 Oxycodone Hydrochloride Capsules Market Size by Type
5.1 Global Oxycodone Hydrochloride Capsules Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Oxycodone Hydrochloride Capsules Revenue by Type (2020-2031)
5.3 Global Oxycodone Hydrochloride Capsules Revenue Market Share by Type (2020-2031)
6 Oxycodone Hydrochloride Capsules Market Size by Application
6.1 Global Oxycodone Hydrochloride Capsules Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Oxycodone Hydrochloride Capsules Revenue by Application (2020-2031)
6.3 Global Oxycodone Hydrochloride Capsules Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 NAPP PHARMACEUTICALS LIMITED
7.1.1 NAPP PHARMACEUTICALS LIMITED Comapny Information
7.1.2 NAPP PHARMACEUTICALS LIMITED Business Overview
7.1.3 NAPP PHARMACEUTICALS LIMITED Oxycodone Hydrochloride Capsules Revenue and Gross Margin (2020-2025)
7.1.4 NAPP PHARMACEUTICALS LIMITED Oxycodone Hydrochloride Capsules Product Portfolio
7.1.5 NAPP PHARMACEUTICALS LIMITED Recent Developments
7.2 Allergan
7.2.1 Allergan Comapny Information
7.2.2 Allergan Business Overview
7.2.3 Allergan Oxycodone Hydrochloride Capsules Revenue and Gross Margin (2020-2025)
7.2.4 Allergan Oxycodone Hydrochloride Capsules Product Portfolio
7.2.5 Allergan Recent Developments
7.3 Hikma Pharmaceuticals
7.3.1 Hikma Pharmaceuticals Comapny Information
7.3.2 Hikma Pharmaceuticals Business Overview
7.3.3 Hikma Pharmaceuticals Oxycodone Hydrochloride Capsules Revenue and Gross Margin (2020-2025)
7.3.4 Hikma Pharmaceuticals Oxycodone Hydrochloride Capsules Product Portfolio
7.3.5 Hikma Pharmaceuticals Recent Developments
7.4 Purdue Pharma
7.4.1 Purdue Pharma Comapny Information
7.4.2 Purdue Pharma Business Overview
7.4.3 Purdue Pharma Oxycodone Hydrochloride Capsules Revenue and Gross Margin (2020-2025)
7.4.4 Purdue Pharma Oxycodone Hydrochloride Capsules Product Portfolio
7.4.5 Purdue Pharma Recent Developments
7.5 Sandoz
7.5.1 Sandoz Comapny Information
7.5.2 Sandoz Business Overview
7.5.3 Sandoz Oxycodone Hydrochloride Capsules Revenue and Gross Margin (2020-2025)
7.5.4 Sandoz Oxycodone Hydrochloride Capsules Product Portfolio
7.5.5 Sandoz Recent Developments
7.6 Zydus Cadila
7.6.1 Zydus Cadila Comapny Information
7.6.2 Zydus Cadila Business Overview
7.6.3 Zydus Cadila Oxycodone Hydrochloride Capsules Revenue and Gross Margin (2020-2025)
7.6.4 Zydus Cadila Oxycodone Hydrochloride Capsules Product Portfolio
7.6.5 Zydus Cadila Recent Developments
7.7 Viatris
7.7.1 Viatris Comapny Information
7.7.2 Viatris Business Overview
7.7.3 Viatris Oxycodone Hydrochloride Capsules Revenue and Gross Margin (2020-2025)
7.7.4 Viatris Oxycodone Hydrochloride Capsules Product Portfolio
7.7.5 Viatris Recent Developments
7.8 Lock Pharma
7.8.1 Lock Pharma Comapny Information
7.8.2 Lock Pharma Business Overview
7.8.3 Lock Pharma Oxycodone Hydrochloride Capsules Revenue and Gross Margin (2020-2025)
7.8.4 Lock Pharma Oxycodone Hydrochloride Capsules Product Portfolio
7.8.5 Lock Pharma Recent Developments
7.9 Teva Pharmaceuticals
7.9.1 Teva Pharmaceuticals Comapny Information
7.9.2 Teva Pharmaceuticals Business Overview
7.9.3 Teva Pharmaceuticals Oxycodone Hydrochloride Capsules Revenue and Gross Margin (2020-2025)
7.9.4 Teva Pharmaceuticals Oxycodone Hydrochloride Capsules Product Portfolio
7.9.5 Teva Pharmaceuticals Recent Developments
8 North America
8.1 North America Oxycodone Hydrochloride Capsules Revenue (2020-2031)
8.2 North America Oxycodone Hydrochloride Capsules Revenue by Type (2020-2031)
8.2.1 North America Oxycodone Hydrochloride Capsules Revenue by Type (2020-2025)
8.2.2 North America Oxycodone Hydrochloride Capsules Revenue by Type (2026-2031)
8.3 North America Oxycodone Hydrochloride Capsules Revenue Share by Type (2020-2031)
8.4 North America Oxycodone Hydrochloride Capsules Revenue by Application (2020-2031)
8.4.1 North America Oxycodone Hydrochloride Capsules Revenue by Application (2020-2025)
8.4.2 North America Oxycodone Hydrochloride Capsules Revenue by Application (2026-2031)
8.5 North America Oxycodone Hydrochloride Capsules Revenue Share by Application (2020-2031)
8.6 North America Oxycodone Hydrochloride Capsules Revenue by Country
8.6.1 North America Oxycodone Hydrochloride Capsules Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Oxycodone Hydrochloride Capsules Revenue by Country (2020-2025)
8.6.3 North America Oxycodone Hydrochloride Capsules Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Oxycodone Hydrochloride Capsules Revenue (2020-2031)
9.2 Europe Oxycodone Hydrochloride Capsules Revenue by Type (2020-2031)
9.2.1 Europe Oxycodone Hydrochloride Capsules Revenue by Type (2020-2025)
9.2.2 Europe Oxycodone Hydrochloride Capsules Revenue by Type (2026-2031)
9.3 Europe Oxycodone Hydrochloride Capsules Revenue Share by Type (2020-2031)
9.4 Europe Oxycodone Hydrochloride Capsules Revenue by Application (2020-2031)
9.4.1 Europe Oxycodone Hydrochloride Capsules Revenue by Application (2020-2025)
9.4.2 Europe Oxycodone Hydrochloride Capsules Revenue by Application (2026-2031)
9.5 Europe Oxycodone Hydrochloride Capsules Revenue Share by Application (2020-2031)
9.6 Europe Oxycodone Hydrochloride Capsules Revenue by Country
9.6.1 Europe Oxycodone Hydrochloride Capsules Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Oxycodone Hydrochloride Capsules Revenue by Country (2020-2025)
9.6.3 Europe Oxycodone Hydrochloride Capsules Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Oxycodone Hydrochloride Capsules Revenue (2020-2031)
10.2 China Oxycodone Hydrochloride Capsules Revenue by Type (2020-2031)
10.2.1 China Oxycodone Hydrochloride Capsules Revenue by Type (2020-2025)
10.2.2 China Oxycodone Hydrochloride Capsules Revenue by Type (2026-2031)
10.3 China Oxycodone Hydrochloride Capsules Revenue Share by Type (2020-2031)
10.4 China Oxycodone Hydrochloride Capsules Revenue by Application (2020-2031)
10.4.1 China Oxycodone Hydrochloride Capsules Revenue by Application (2020-2025)
10.4.2 China Oxycodone Hydrochloride Capsules Revenue by Application (2026-2031)
10.5 China Oxycodone Hydrochloride Capsules Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Oxycodone Hydrochloride Capsules Revenue (2020-2031)
11.2 Asia Oxycodone Hydrochloride Capsules Revenue by Type (2020-2031)
11.2.1 Asia Oxycodone Hydrochloride Capsules Revenue by Type (2020-2025)
11.2.2 Asia Oxycodone Hydrochloride Capsules Revenue by Type (2026-2031)
11.3 Asia Oxycodone Hydrochloride Capsules Revenue Share by Type (2020-2031)
11.4 Asia Oxycodone Hydrochloride Capsules Revenue by Application (2020-2031)
11.4.1 Asia Oxycodone Hydrochloride Capsules Revenue by Application (2020-2025)
11.4.2 Asia Oxycodone Hydrochloride Capsules Revenue by Application (2026-2031)
11.5 Asia Oxycodone Hydrochloride Capsules Revenue Share by Application (2020-2031)
11.6 Asia Oxycodone Hydrochloride Capsules Revenue by Country
11.6.1 Asia Oxycodone Hydrochloride Capsules Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Oxycodone Hydrochloride Capsules Revenue by Country (2020-2025)
11.6.3 Asia Oxycodone Hydrochloride Capsules Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Oxycodone Hydrochloride Capsules Revenue (2020-2031)
12.2 SAMEA Oxycodone Hydrochloride Capsules Revenue by Type (2020-2031)
12.2.1 SAMEA Oxycodone Hydrochloride Capsules Revenue by Type (2020-2025)
12.2.2 SAMEA Oxycodone Hydrochloride Capsules Revenue by Type (2026-2031)
12.3 SAMEA Oxycodone Hydrochloride Capsules Revenue Share by Type (2020-2031)
12.4 SAMEA Oxycodone Hydrochloride Capsules Revenue by Application (2020-2031)
12.4.1 SAMEA Oxycodone Hydrochloride Capsules Revenue by Application (2020-2025)
12.4.2 SAMEA Oxycodone Hydrochloride Capsules Revenue by Application (2026-2031)
12.5 SAMEA Oxycodone Hydrochloride Capsules Revenue Share by Application (2020-2031)
12.6 SAMEA Oxycodone Hydrochloride Capsules Revenue by Country
12.6.1 SAMEA Oxycodone Hydrochloride Capsules Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Oxycodone Hydrochloride Capsules Revenue by Country (2020-2025)
12.6.3 SAMEA Oxycodone Hydrochloride Capsules Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings